Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects

Stem cell therapy is considered an optimistic approach to replace current treatments for cartilage defects. Recently, human urine-derived stem cells (hUSCs), which are isolated from the urine, are studied as a promising candidate for many tissue engineering therapies due to their multipotency and su...

Full description

Saved in:
Bibliographic Details
Published in:Stem cells international 2018-01, Vol.2018 (2018), p.1-14
Main Authors: Xiang, Zhou, Peng, Kun, Peng, Jing, Xing, Fei, Li, Lang, Chen, Long, Wang, Yuanzheng
Format: Article
Language:English
Subjects:
Acids
Aggrecan
Arthritis
Biomedical materials
Bone marrow
Cartilage
Cell growth
Collagen
Collagen (type II)
Defects
Ethylenediaminetetraacetic acid
FDA approval
Flow cytometry
Gene expression
Health care
Human wastes
Hyaluronic acid
Immunohistochemistry
Joint surgery
Knee
Laboratory animals
Proteins
Regeneration
Rheumatology
Stem cells
Studies
Therapy
Tissue engineering
Toluidine
Toluidine blue
Transplantation
Urine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c635t-b7ab08cfbdeb1783376d75b6b23adc40983d6d5ae12284b3c79809d7013967803
cites cdi_FETCH-LOGICAL-c635t-b7ab08cfbdeb1783376d75b6b23adc40983d6d5ae12284b3c79809d7013967803
container_end_page 14
container_issue 2018
container_start_page 1
container_title Stem cells international
container_volume 2018
creator Xiang, Zhou
Peng, Kun
Peng, Jing
Xing, Fei
Li, Lang
Chen, Long
Wang, Yuanzheng
description Stem cell therapy is considered an optimistic approach to replace current treatments for cartilage defects. Recently, human urine-derived stem cells (hUSCs), which are isolated from the urine, are studied as a promising candidate for many tissue engineering therapies due to their multipotency and sufficient proliferation activities. However, it has not yet been reported whether hUSCs can be employed in cartilage defects. In this study, we revealed that induced hUSCs expressed chondrogenic-related proteins, including aggrecan and collagen II, and their gene expression levels were upregulated in vitro. Moreover, we combined hUSCs with hyaluronic acid (HA) and injected hUSCs-HA into a rabbit knee joint with cartilage defect. Twelve weeks after the injection, the histologic analyses (HE, toluidine blue, and Masson trichrome staining), immunohistochemistry (aggrecan and collagen II), and histologic grade of the sample indicated that hUSCs-HA could stimulate much more neocartilage formation compared with hUSCs alone, pure HA, and saline, which only induced the modest cartilage regeneration. In this study, we demonstrated that hUSCs could be a potential cell source for stem cell therapies to treat cartilage-related defects in the future.
doi_str_mv 10.1155/2018/4686259
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_899cdbfffa8641bb9ccaa96f80b7999b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A587260542</galeid><doaj_id>oai_doaj_org_article_899cdbfffa8641bb9ccaa96f80b7999b</doaj_id><sourcerecordid>A587260542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c635t-b7ab08cfbdeb1783376d75b6b23adc40983d6d5ae12284b3c79809d7013967803</originalsourceid><addsrcrecordid>eNqNkttrFDEUxgdRbKl981kGBBF02lxmcumDULdqCwUFu-BbyHU3y8xkTWYq_e_NdNdtV3wweUg4-Z0v53ycongJwQmETXOKAGSnNWEENfxJcQgJoxUnlD3d3cmPg-I4pRXIC3NQA_S8OECckqaG-LCYX46d7Mt59L2tLmz0t9aU3wfblTPbtums_BYG2w9etqUL8T5YfZQpQzdLG-X6rgyunMk4-FYubHlhndVDelE8c7JN9nh7HhXzz59uZpfV9dcvV7Pz60oT3AyVolIBpp0yVkHKMKbE0EYRhbA0ugacYUNMIy1EiNUKa8oZ4IYCiKcmAT4qrja6JsiVWEffyXgngvTiPhDiQkyl6dYKxrk2yjknGamhUlxrKTlxDCjKOVdZ68NGaz2qzhqdu46y3RPdf-n9UizCrWg4RnVDssDbrUAMP0ebBtH5pLNhsrdhTAJl_xmjNagz-vovdBXG2GerJgrl7nKRD9RC5gZ870L-V0-i4rxhFBHQ1ChTJ_-g8ja28zr01vkc30t48yhhaWU7LFNox8GHPu2D7zegjiGlaN3ODAjENH5iGj-xHb-Mv3ps4A7-M2wZeLcBlr438pf_TzmbGevkA40griHAvwG-ruhM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2032396864</pqid></control><display><type>article</type><title>Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects</title><source>Access via ProQuest (Open Access)</source><source>Wiley_OA刊</source><source>PubMed Central</source><creator>Xiang, Zhou ; Peng, Kun ; Peng, Jing ; Xing, Fei ; Li, Lang ; Chen, Long ; Wang, Yuanzheng</creator><contributor>Sun, Hui Bin ; Hui Bin Sun</contributor><creatorcontrib>Xiang, Zhou ; Peng, Kun ; Peng, Jing ; Xing, Fei ; Li, Lang ; Chen, Long ; Wang, Yuanzheng ; Sun, Hui Bin ; Hui Bin Sun</creatorcontrib><description>Stem cell therapy is considered an optimistic approach to replace current treatments for cartilage defects. Recently, human urine-derived stem cells (hUSCs), which are isolated from the urine, are studied as a promising candidate for many tissue engineering therapies due to their multipotency and sufficient proliferation activities. However, it has not yet been reported whether hUSCs can be employed in cartilage defects. In this study, we revealed that induced hUSCs expressed chondrogenic-related proteins, including aggrecan and collagen II, and their gene expression levels were upregulated in vitro. Moreover, we combined hUSCs with hyaluronic acid (HA) and injected hUSCs-HA into a rabbit knee joint with cartilage defect. Twelve weeks after the injection, the histologic analyses (HE, toluidine blue, and Masson trichrome staining), immunohistochemistry (aggrecan and collagen II), and histologic grade of the sample indicated that hUSCs-HA could stimulate much more neocartilage formation compared with hUSCs alone, pure HA, and saline, which only induced the modest cartilage regeneration. In this study, we demonstrated that hUSCs could be a potential cell source for stem cell therapies to treat cartilage-related defects in the future.</description><identifier>ISSN: 1687-966X</identifier><identifier>ISSN: 1687-9678</identifier><identifier>EISSN: 1687-9678</identifier><identifier>DOI: 10.1155/2018/4686259</identifier><identifier>PMID: 29765413</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Acids ; Aggrecan ; Arthritis ; Biomedical materials ; Bone marrow ; Cartilage ; Cell growth ; Collagen ; Collagen (type II) ; Defects ; Ethylenediaminetetraacetic acid ; FDA approval ; Flow cytometry ; Gene expression ; Health care ; Human wastes ; Hyaluronic acid ; Immunohistochemistry ; Joint surgery ; Knee ; Laboratory animals ; Proteins ; Regeneration ; Rheumatology ; Stem cells ; Studies ; Therapy ; Tissue engineering ; Toluidine ; Toluidine blue ; Transplantation ; Urine</subject><ispartof>Stem cells international, 2018-01, Vol.2018 (2018), p.1-14</ispartof><rights>Copyright © 2018 Long Chen et al.</rights><rights>COPYRIGHT 2018 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2018 Long Chen et al.; This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2018 Long Chen et al. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c635t-b7ab08cfbdeb1783376d75b6b23adc40983d6d5ae12284b3c79809d7013967803</citedby><cites>FETCH-LOGICAL-c635t-b7ab08cfbdeb1783376d75b6b23adc40983d6d5ae12284b3c79809d7013967803</cites><orcidid>0000-0003-2816-0500</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2032396864/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2032396864?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29765413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Sun, Hui Bin</contributor><contributor>Hui Bin Sun</contributor><creatorcontrib>Xiang, Zhou</creatorcontrib><creatorcontrib>Peng, Kun</creatorcontrib><creatorcontrib>Peng, Jing</creatorcontrib><creatorcontrib>Xing, Fei</creatorcontrib><creatorcontrib>Li, Lang</creatorcontrib><creatorcontrib>Chen, Long</creatorcontrib><creatorcontrib>Wang, Yuanzheng</creatorcontrib><title>Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects</title><title>Stem cells international</title><addtitle>Stem Cells Int</addtitle><description>Stem cell therapy is considered an optimistic approach to replace current treatments for cartilage defects. Recently, human urine-derived stem cells (hUSCs), which are isolated from the urine, are studied as a promising candidate for many tissue engineering therapies due to their multipotency and sufficient proliferation activities. However, it has not yet been reported whether hUSCs can be employed in cartilage defects. In this study, we revealed that induced hUSCs expressed chondrogenic-related proteins, including aggrecan and collagen II, and their gene expression levels were upregulated in vitro. Moreover, we combined hUSCs with hyaluronic acid (HA) and injected hUSCs-HA into a rabbit knee joint with cartilage defect. Twelve weeks after the injection, the histologic analyses (HE, toluidine blue, and Masson trichrome staining), immunohistochemistry (aggrecan and collagen II), and histologic grade of the sample indicated that hUSCs-HA could stimulate much more neocartilage formation compared with hUSCs alone, pure HA, and saline, which only induced the modest cartilage regeneration. In this study, we demonstrated that hUSCs could be a potential cell source for stem cell therapies to treat cartilage-related defects in the future.</description><subject>Acids</subject><subject>Aggrecan</subject><subject>Arthritis</subject><subject>Biomedical materials</subject><subject>Bone marrow</subject><subject>Cartilage</subject><subject>Cell growth</subject><subject>Collagen</subject><subject>Collagen (type II)</subject><subject>Defects</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>FDA approval</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>Health care</subject><subject>Human wastes</subject><subject>Hyaluronic acid</subject><subject>Immunohistochemistry</subject><subject>Joint surgery</subject><subject>Knee</subject><subject>Laboratory animals</subject><subject>Proteins</subject><subject>Regeneration</subject><subject>Rheumatology</subject><subject>Stem cells</subject><subject>Studies</subject><subject>Therapy</subject><subject>Tissue engineering</subject><subject>Toluidine</subject><subject>Toluidine blue</subject><subject>Transplantation</subject><subject>Urine</subject><issn>1687-966X</issn><issn>1687-9678</issn><issn>1687-9678</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkttrFDEUxgdRbKl981kGBBF02lxmcumDULdqCwUFu-BbyHU3y8xkTWYq_e_NdNdtV3wweUg4-Z0v53ycongJwQmETXOKAGSnNWEENfxJcQgJoxUnlD3d3cmPg-I4pRXIC3NQA_S8OECckqaG-LCYX46d7Mt59L2tLmz0t9aU3wfblTPbtums_BYG2w9etqUL8T5YfZQpQzdLG-X6rgyunMk4-FYubHlhndVDelE8c7JN9nh7HhXzz59uZpfV9dcvV7Pz60oT3AyVolIBpp0yVkHKMKbE0EYRhbA0ugacYUNMIy1EiNUKa8oZ4IYCiKcmAT4qrja6JsiVWEffyXgngvTiPhDiQkyl6dYKxrk2yjknGamhUlxrKTlxDCjKOVdZ68NGaz2qzhqdu46y3RPdf-n9UizCrWg4RnVDssDbrUAMP0ebBtH5pLNhsrdhTAJl_xmjNagz-vovdBXG2GerJgrl7nKRD9RC5gZ870L-V0-i4rxhFBHQ1ChTJ_-g8ja28zr01vkc30t48yhhaWU7LFNox8GHPu2D7zegjiGlaN3ODAjENH5iGj-xHb-Mv3ps4A7-M2wZeLcBlr438pf_TzmbGevkA40griHAvwG-ruhM</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Xiang, Zhou</creator><creator>Peng, Kun</creator><creator>Peng, Jing</creator><creator>Xing, Fei</creator><creator>Li, Lang</creator><creator>Chen, Long</creator><creator>Wang, Yuanzheng</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2816-0500</orcidid></search><sort><creationdate>20180101</creationdate><title>Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects</title><author>Xiang, Zhou ; Peng, Kun ; Peng, Jing ; Xing, Fei ; Li, Lang ; Chen, Long ; Wang, Yuanzheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c635t-b7ab08cfbdeb1783376d75b6b23adc40983d6d5ae12284b3c79809d7013967803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acids</topic><topic>Aggrecan</topic><topic>Arthritis</topic><topic>Biomedical materials</topic><topic>Bone marrow</topic><topic>Cartilage</topic><topic>Cell growth</topic><topic>Collagen</topic><topic>Collagen (type II)</topic><topic>Defects</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>FDA approval</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>Health care</topic><topic>Human wastes</topic><topic>Hyaluronic acid</topic><topic>Immunohistochemistry</topic><topic>Joint surgery</topic><topic>Knee</topic><topic>Laboratory animals</topic><topic>Proteins</topic><topic>Regeneration</topic><topic>Rheumatology</topic><topic>Stem cells</topic><topic>Studies</topic><topic>Therapy</topic><topic>Tissue engineering</topic><topic>Toluidine</topic><topic>Toluidine blue</topic><topic>Transplantation</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xiang, Zhou</creatorcontrib><creatorcontrib>Peng, Kun</creatorcontrib><creatorcontrib>Peng, Jing</creatorcontrib><creatorcontrib>Xing, Fei</creatorcontrib><creatorcontrib>Li, Lang</creatorcontrib><creatorcontrib>Chen, Long</creatorcontrib><creatorcontrib>Wang, Yuanzheng</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Stem cells international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xiang, Zhou</au><au>Peng, Kun</au><au>Peng, Jing</au><au>Xing, Fei</au><au>Li, Lang</au><au>Chen, Long</au><au>Wang, Yuanzheng</au><au>Sun, Hui Bin</au><au>Hui Bin Sun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects</atitle><jtitle>Stem cells international</jtitle><addtitle>Stem Cells Int</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>2018</volume><issue>2018</issue><spage>1</spage><epage>14</epage><pages>1-14</pages><issn>1687-966X</issn><issn>1687-9678</issn><eissn>1687-9678</eissn><abstract>Stem cell therapy is considered an optimistic approach to replace current treatments for cartilage defects. Recently, human urine-derived stem cells (hUSCs), which are isolated from the urine, are studied as a promising candidate for many tissue engineering therapies due to their multipotency and sufficient proliferation activities. However, it has not yet been reported whether hUSCs can be employed in cartilage defects. In this study, we revealed that induced hUSCs expressed chondrogenic-related proteins, including aggrecan and collagen II, and their gene expression levels were upregulated in vitro. Moreover, we combined hUSCs with hyaluronic acid (HA) and injected hUSCs-HA into a rabbit knee joint with cartilage defect. Twelve weeks after the injection, the histologic analyses (HE, toluidine blue, and Masson trichrome staining), immunohistochemistry (aggrecan and collagen II), and histologic grade of the sample indicated that hUSCs-HA could stimulate much more neocartilage formation compared with hUSCs alone, pure HA, and saline, which only induced the modest cartilage regeneration. In this study, we demonstrated that hUSCs could be a potential cell source for stem cell therapies to treat cartilage-related defects in the future.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>29765413</pmid><doi>10.1155/2018/4686259</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-2816-0500</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1687-966X
ispartof Stem cells international, 2018-01, Vol.2018 (2018), p.1-14
issn 1687-966X
1687-9678
1687-9678
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_899cdbfffa8641bb9ccaa96f80b7999b
source Access via ProQuest (Open Access); Wiley_OA刊; PubMed Central
subjects Acids
Aggrecan
Arthritis
Biomedical materials
Bone marrow
Cartilage
Cell growth
Collagen
Collagen (type II)
Defects
Ethylenediaminetetraacetic acid
FDA approval
Flow cytometry
Gene expression
Health care
Human wastes
Hyaluronic acid
Immunohistochemistry
Joint surgery
Knee
Laboratory animals
Proteins
Regeneration
Rheumatology
Stem cells
Studies
Therapy
Tissue engineering
Toluidine
Toluidine blue
Transplantation
Urine
title Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20Urine-Derived%20Stem%20Cells:%20Potential%20for%20Cell-Based%20Therapy%20of%20Cartilage%20Defects&rft.jtitle=Stem%20cells%20international&rft.au=Xiang,%20Zhou&rft.date=2018-01-01&rft.volume=2018&rft.issue=2018&rft.spage=1&rft.epage=14&rft.pages=1-14&rft.issn=1687-966X&rft.eissn=1687-9678&rft_id=info:doi/10.1155/2018/4686259&rft_dat=%3Cgale_doaj_%3EA587260542%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c635t-b7ab08cfbdeb1783376d75b6b23adc40983d6d5ae12284b3c79809d7013967803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2032396864&rft_id=info:pmid/29765413&rft_galeid=A587260542&rfr_iscdi=true